🇺🇸 FDA
Company

Sana

Sana Biotechnology

SANA biotech USA

Quick answer

Sana is a biotech company (SANA) headquartered in SEATTLE, WA, USA with 12 tracked pipeline programs.

Pipeline (12)

project

Dexmedetomidine injection

Post Spinal Shivering

Phase 2 · small_molecule · active

1 trials project

HCQ01

2019 Novel Coronavirus

Phase 2 · small_molecule · active

2 trials project

Hydroxyurea

Thalassemia, Beta

Phase 2 · small_molecule · active

1 trials project

Myocet (Non-pegylated liposomal doxorubicin (NPLD))

Breast Cancer

Phase 2 · small_molecule · completed

1 trials project

Methotrexate

Chronic Plaque Psoriasis

Phase 1 · small_molecule · active

1 trials project

SC262

Non Hodgkin's Lymphoma

Phase 1 · small_molecule · active

1 trials project

SC291

Non Hodgkin Lymphoma

Phase 1 · small_molecule · active

1 trials project

SC291

Lupus Erythematosus

Phase 1 · mab · active

1 trials project

UP421

Type1diabetes

Phase 1 · mab · active

1 trials project

Liraglutide

Morbid Obesity

Approved · small_molecule · completed

1 trials project

Sana Device (Control)

Fibromyalgia

Unknown · small_molecule · terminated

1 trials project

dexmedetomidine

Laparoscopic Cholecystectomy

Unknown · small_molecule · active

1 trials

Drugs (2)

drug

cycloserine

SEROMYCIN

 drug

dolutegravir

DOLUTEGRAVIR

Patents (8)

patent

US 12427199

Self-assembled diblock copolymers composed of pegmema and drug bearing polymeric

Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12409213

Live attenuated oral vaccine against shigellosis and typhoid fever

Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12246059

Stable hybrid FC fusion G-CSF formulation

Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12171822

Infectious plasmodium sporozoites grown in vitro

Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12156870

Antibody drug conjugates comprising sting agonists

Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12129288

Polynucleotides heterodimers of soluble interferon receptors and uses thereof

Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12077543

P2X3 and/or P2X2/3 compounds and methods

Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11987628

Methods and compositions for modulating CAR-T activity

Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)